Overview

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
To monitor use in real practice including adverse events and efficacy on Sutent capsules (Sunitinib malate)
Details
Lead Sponsor:
Pfizer
Treatments:
Sunitinib